Prospective Study of the Impact of Sleeve Gastrectomy on Gastro-esophageal Junction Function (FFSI)
Primary Purpose
Morbid Obesity
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Laparoscopic sleeve gastrectomy
Sponsored by
About this trial
This is an interventional treatment trial for Morbid Obesity focused on measuring Sleeve gastrectomy, Oesogastric junction - GEJ, Dynamic MRI Imaging
Eligibility Criteria
Inclusion Criteria:
- Patient, male or female over 18 years old
- Patient scheduled to undergo a sleeve gastrectomy for obesity
- Patient with surgical indication validated by the obesity multidisciplinary meeting (RCP)
- Patient able to understand the study and to provide written informed consent
- Patient registered with the French social security regime
Non-inclusion criteria:
- Patient unable to give written informed consent
- Patient presenting contra-indication to the conduct of an MRI (claustrophobia, implantable medical devices)
- Patient presenting risks of allergic reaction to MRI contrast agents (gadolinium)
- Patient presenting, in the investigator's judgment, a condition or disease preventing their participation to study procedures
- Patient pregnant or breast-feeding
- Patient within exclusion period from other clinical trial
- Patient having forfeited their freedom of an administrative or legal obligation
- Patient being under guardianship
Sites / Locations
- Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Sleeve gastrectomy
Arm Description
All patients will undergo sleeve gastrectomy
Outcomes
Primary Outcome Measures
Number of patients with postoperative GIQLI score greater than preoperative score
Patients with postoperative GIQLI (Gastro-Intestinal Quality of Life Index) score greater than preoperative score
Secondary Outcome Measures
Quality of life (GIQLI)
Quality of life (Gastro-Intestinal Quality of Life Index)
GERD and dysphagia symptoms (GSAS questionnaire)
GERD (Gastroesophageal Reflux Disease) Symptom Assessment Scale
Functional examinations
Include:
Dynamic MRI
High resolution manometry
pH impedance
upper gastro-intestinal study (UGI)
EndoFLIP® measures
Measurements provided by EndoFlip probe : GEJ distensibility, diameter, pressure
Surgical video analysis
Analysis of surgery videos to detect technical "errors" explaining clinical and/or functional outcome
Per and post-operative complications
Complications occuring during surgery and within 6 months of surgery (reach of 50% of excess weight loss)
Cost of exploratory exams
Cost of exploratory exams
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01980420
Brief Title
Prospective Study of the Impact of Sleeve Gastrectomy on Gastro-esophageal Junction Function
Acronym
FFSI
Official Title
Prospective Study of the Impact of Sleeve Gastrectomy on Gastro-esophageal Junction Function
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
IHU Strasbourg
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Improved results for sleeve gastrectomy could be possible if more was known about the surgical / mechanical factors that affect outcome.
Detailed Description
Effectiveness of sleeve gastrectomy is between gastric banding and gastric bypass. However, a proportion of patients that undergo surgery, report troublesome and persistent dysphagia, pain, new onset or worsening of gastro-esophageal reflux (GER) requiring treatment. Improved results for sleeve gastrectomy could be possible if more was known about the surgical / mechanical factors that affect outcome. Current investigations based on traditional intra-luminal imaging (endoscopy) and radiology (UGI series) may not provide adequate preoperative assessment of esophago-gastric dynamics. Current practice in the creation of a sleeve gastrectomy involves the use of a bougie or endoscope around which the sleeve is stapled. There is no consensus on the diameter of this bougie and this intraoperative calibration may alter the gastro-esophageal junction (GEJ) anatomy, does not provide real time physiology feedback, and allows only for a rough approximation of the size of the sleeve providing no information about the distensibility and pressure gradient of the newly created gastric tube as it is filled. A more distensible sleeve will have lower intra-gastric pressure, and thus will theoretically be expected to reduce the incidence of side effects. As laparoscopic sleeve gastrectomy is performed with increasing frequency, there is a need for development of tools to assist the surgeon in modeling properly and standardize the gastroplasty. This study will be based on a strict assessment of the anatomical and functional characteristics of the "ideal "gastric sleeve, using existing imaging modalities (endoscopy - CT scan- MRI - HRM).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity
Keywords
Sleeve gastrectomy, Oesogastric junction - GEJ, Dynamic MRI Imaging
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sleeve gastrectomy
Arm Type
Other
Arm Description
All patients will undergo sleeve gastrectomy
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic sleeve gastrectomy
Intervention Description
Conventional laparoscopic sleeve gastrectomy using EndoFLIP® probe to provide measures on the distensibility of gastro-esophageal junction (GEJ) and gastric tube.
Primary Outcome Measure Information:
Title
Number of patients with postoperative GIQLI score greater than preoperative score
Description
Patients with postoperative GIQLI (Gastro-Intestinal Quality of Life Index) score greater than preoperative score
Time Frame
50% excess weight loss (about 6 months post surgery)
Secondary Outcome Measure Information:
Title
Quality of life (GIQLI)
Description
Quality of life (Gastro-Intestinal Quality of Life Index)
Time Frame
50% of excess weight loss (about 6 months post surgery)
Title
GERD and dysphagia symptoms (GSAS questionnaire)
Description
GERD (Gastroesophageal Reflux Disease) Symptom Assessment Scale
Time Frame
50% of excess weight loss (about 6 months post surgery)
Title
Functional examinations
Description
Include:
Dynamic MRI
High resolution manometry
pH impedance
upper gastro-intestinal study (UGI)
Time Frame
50% of excess weight loss (about 6 months post surgery)
Title
EndoFLIP® measures
Description
Measurements provided by EndoFlip probe : GEJ distensibility, diameter, pressure
Time Frame
Intra-operatively
Title
Surgical video analysis
Description
Analysis of surgery videos to detect technical "errors" explaining clinical and/or functional outcome
Time Frame
within 6 months post surgery
Title
Per and post-operative complications
Description
Complications occuring during surgery and within 6 months of surgery (reach of 50% of excess weight loss)
Time Frame
within 6 months post surgery
Title
Cost of exploratory exams
Time Frame
50% excess weight loss (about 6 months post surgery)
Title
Cost of exploratory exams
Time Frame
Within 2 months prior to surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient, male or female over 18 years old
Patient scheduled to undergo a sleeve gastrectomy for obesity
Patient with surgical indication validated by the obesity multidisciplinary meeting (RCP)
Patient able to understand the study and to provide written informed consent
Patient registered with the French social security regime
Non-inclusion criteria:
Patient unable to give written informed consent
Patient presenting contra-indication to the conduct of an MRI (claustrophobia, implantable medical devices)
Patient presenting risks of allergic reaction to MRI contrast agents (gadolinium)
Patient presenting, in the investigator's judgment, a condition or disease preventing their participation to study procedures
Patient pregnant or breast-feeding
Patient within exclusion period from other clinical trial
Patient having forfeited their freedom of an administrative or legal obligation
Patient being under guardianship
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Silvana Perretta, Pr
Organizational Affiliation
Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
City
Strasbourg
ZIP/Postal Code
67000
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
32207049
Citation
Quero G, Fiorillo C, Dallemagne B, Mascagni P, Curcic J, Fox M, Perretta S. The Causes of Gastroesophageal Reflux after Laparoscopic Sleeve Gastrectomy: Quantitative Assessment of the Structure and Function of the Esophagogastric Junction by Magnetic Resonance Imaging and High-Resolution Manometry. Obes Surg. 2020 Jun;30(6):2108-2117. doi: 10.1007/s11695-020-04438-y.
Results Reference
derived
Learn more about this trial
Prospective Study of the Impact of Sleeve Gastrectomy on Gastro-esophageal Junction Function
We'll reach out to this number within 24 hrs